Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer

Surrogate markers may help predict the effects of first-line treatment on survival. This metaregression analysis examines the relationship between several surrogate markers and survival in women with advanced breast cancer after receiving first-line combination anthracycline chemotherapy 5-fluoroura...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackshaw, A, Knight, A, Barrett-Lee, P, Leonard, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361525/
https://www.ncbi.nlm.nih.gov/pubmed/16278665
http://dx.doi.org/10.1038/sj.bjc.6602858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361525/
https://www.ncbi.nlm.nih.gov/pubmed/16278665
http://dx.doi.org/10.1038/sj.bjc.6602858

Ejemplares similares